Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million.
Withdrawn from consideration
Email me when A 1526 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track A 1526. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill establishes a two‑year Psilocybin Behavioral Health Access and Therapy Pilot Program, funding $6 million to support research and treatment at one hospital in each of the state’s northern, central, and southern regions. An advisory board of 11 members will guide the program, ensure compliance with FDA and DEA rules, and report findings to the governor and legislature. The goal is to evaluate whether a statewide, safe and affordable psilocybin treatment system could be created.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about A 1526
3 free questions a day, no accountHistory
- Withdrawn Because Approved P.L.2025, c.296.
- Introduced, Referred to Assembly Health Committee
Sponsors
- Calabrese, Clinton · sponsor
- Egan, Kevin P.
- Haider, Shama A.
- Speight, Shanique
- Verrelli, Anthony S.
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when A 1526 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track A 1526 freeOr ask your AI assistant about A 1526 directly:
Add to Claude, ChatGPT or Cursor